Zobrazeno 1 - 10
of 104
pro vyhledávání: '"Po-Lin Tseng"'
Autor:
Hsin-Wei Fang, Po-Lin Tseng, Tsung-Hui Hu, Jing-Houng Wang, Chao-Hung Hung, Sheng-Nan Lu, Chien-Hung Chen
Publikováno v:
Virology Journal, Vol 21, Iss 1, Pp 1-12 (2024)
Abstract Background No study has comparing hepatitis B virus (HBV) relapse rates among patients with both cancer and hepatitis B e antigen (HBeAg)-negative chronic hepatitis B (CHB) who completed anti-viral prophylaxis for chemotherapy and then stopp
Externí odkaz:
https://doaj.org/article/f181034400bd407baebe632e815d3c5b
Autor:
Shih-Yu Yang, Tsung-Hui Hu, Yeh-Pin Chou, Yuan-Hung Kuo, Ming-Chao Tsai, Kuo-Chin Chang, Yi-Hao Yen, Po-Lin Tseng
Publikováno v:
Journal of Infection and Public Health, Vol 16, Iss 11, Pp 1852-1859 (2023)
Background: Prophylaxis antiviral therapy is recommended for patients with hepatitis B receiving chemotherapy but the ideal treatment duration after chemotherapy cessation needs more evidence for clarification. Aims: This study aimed to compare the r
Externí odkaz:
https://doaj.org/article/2b55cf6c24544b049bd644f0f356897a
Autor:
Kuo-Chin Chang, Yi-Hao Ye, Cheng-Kun Wu, Ming-Tsung Lin, Ming-Chao Tsai, Po-Lin Tseng, Tsung-Hui Hu
Publikováno v:
Journal of the Formosan Medical Association, Vol 117, Iss 11, Pp 1011-1018 (2018)
Background/Purpose: Although antiviral therapy reduces development of hepatocellular carcinoma (HCC) in patients with chronic hepatitis C (CHC), HCC often develops in patients with non-sustained virologic response (non-SVR). We aimed to evaluate risk
Externí odkaz:
https://doaj.org/article/b0f77cd19bcb43b1bf4ea70c75ce6a42
Autor:
Yi-Hao Yen, Ming-Chao Tsai, Cheng-Kun Wu, Kuo-Chin Chang, Chao-Hung Hung, King-Wah Chiu, Sheng-Nan Lu, Jing-Houng Wang, Chien-Hung Chen, Kwong-Ming Kee, Yuan-Hung Kuo, Po-Lin Tseng, Ming-Tsung Lin, Chao-Min Huang, Jung-Ting Lin, Tsung-Hui Hu
Publikováno v:
Journal of the Formosan Medical Association, Vol 117, Iss 9, Pp 833-840 (2018)
Background/Purpose: Prdevious meta-analyses assess whether or not patatin-like phospholipase domain containing 3 (PNPLA3) (rs738409 C > G) was associated with increased risk of hepatocellular carcinoma (HCC) in Caucasians patients with hepatitis C vi
Externí odkaz:
https://doaj.org/article/f91f66c4eb634580b34681c6817aa48b
Autor:
Yi-Hao Yen, Kuo-Chin Chang, Ming-Chao Tsai, Po-Lin Tseng, Ming-Tsung Lin, Cheng-Kun Wu, Jung-Ting Lin, Tsung-Hui Hu, Jing-Houng Wang, Chien-Hung Chen
Publikováno v:
Journal of the Formosan Medical Association, Vol 117, Iss 4, Pp 268-275 (2018)
Background/Purpose: Metabolic risk factors are associated with liver fibrosis. Whether or not metabolic risk factors affect the severity of liver fibrosis in patients with chronic hepatitis B (CHB), chronic hepatitis C (CHC), or risk factors associat
Externí odkaz:
https://doaj.org/article/6970751adaef4fb7a22c8b8441067ed2
Autor:
Yi-Hao Yen, Jung-Fu Chen, Cheng-Kun Wu, Ming-Tsung Lin, Kuo-Chin Chang, Po-Lin Tseng, Ming-Chao Tsai, Jung-Ting Lin, Tsung-Hui Hu
Publikováno v:
Journal of the Formosan Medical Association, Vol 116, Iss 11, Pp 852-861 (2017)
Controlled attenuation parameter (CAP) is a method for measuring steatosis based on FibroScan. Despite observer dependency, ultrasound (US) robustly diagnoses moderate and severe steatosis. Here, we aimed to evaluate the correlation of CAP with US-id
Externí odkaz:
https://doaj.org/article/4858e34ead254b24937ba57f4d8ac1e6
Autor:
Yi-Hao Yen, Jin-Bor Chen, Ben-Chung Cheng, Jung-Fu Chen, Kuo-Chin Chang, Po-Lin Tseng, Cheng-Kun Wu, Ming-Chao Tsai, Ming-Tsung Lin, Tsung-Hui Hu
Publikováno v:
PLoS ONE, Vol 12, Iss 4, p e0176027 (2017)
Controlled attenuation parameter (CAP) is a non-invasive method for measuring hepatic steatosis (HS). Non-alcoholic fatty liver disease (NAFLD) is closely related to cardiovascular diseases (CVDs). CVDs are the leading cause of morbidity and mortalit
Externí odkaz:
https://doaj.org/article/09743ee5af7547f69b153a5efb901090
Autor:
Chao-Min Huang, Kuo-Chin Chang, Chao-Hung Hung, King-Wah Chiu, Sheng-Nan Lu, Jing-Houng Wang, Chien-Hung Chen, Kwong-Ming Kee, Yuan-Hung Kuo, Ming-Chao Tsai, Po-Lin Tseng, Ming-Tsung Lin, Cheng-Kun Wu, Tsung-Hui Hu, Chung-Lung Cho, Yi-Hao Yen
Publikováno v:
PLoS ONE, Vol 12, Iss 8, p e0182204 (2017)
BACKGROUND AND AIMS:A recent meta-analysis revealed that the genotype PNPLA3 rs738409 GG is associated with a higher risk of hepatic steatosis (HS) in Caucasian patients with chronic hepatitis C (CHC). However, controversial results were found regard
Externí odkaz:
https://doaj.org/article/48f3c2842fe94c288e2e2ecfb3d8508b
Autor:
Chao-Tung Chen, Jing-Yi Chen, Jing-Houng Wang, Kuo-Chin Chang, Po-Lin Tseng, Kwong-Ming Kee, Pao-Fei Chen, Lin-San Tsai, Shu-Chuan Chen, Sheng-Che Lin, Sheng-Nan Lu
Publikováno v:
Kaohsiung Journal of Medical Sciences, Vol 29, Iss 8, Pp 451-459 (2013)
A prominent factor in hepatocellular carcinoma (HCC) is chronic infection with hepatitis B virus (HBV) and hepatitis C virus (HCV). Diabetes mellitus (DM), metabolic syndrome (MetS), and obesity have also been implicated in HCC development, but these
Externí odkaz:
https://doaj.org/article/0dc224df7d4145fbaa5becfd302b3d62
Autor:
Po-Lin Tseng, Jing-Houng Wang, Chao-Hung Hung, Hung-Da Tung, Tsung-Ming Chen, Wu-Shiung Huang, Shiann-Long Liu, Tsung-Hui Hu, Chuan-Mo Lee, Sheng-Nan Lu
Publikováno v:
Kaohsiung Journal of Medical Sciences, Vol 29, Iss 7, Pp 385-395 (2013)
Several noninvasive indices have been proposed for predicting liver cirrhosis (LC), particularly in chronic hepatitis C (CHC). In this study, noninvasive indices for predicting LC and hepatocellular carcinoma (HCC) were compared. A total of 119 chron
Externí odkaz:
https://doaj.org/article/cddaa01657404abf94448250daa50991